Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure
- 1 November 2005
- journal article
- Published by Elsevier in Kidney International
- Vol. 68 (5) , 2381-2388
- https://doi.org/10.1111/j.1523-1755.2005.00701.x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Molecular mechanisms modifying the peritoneal membrane exposed to peritoneal dialysisClinical Nephrology, 2003
- Tamoxifen and Estrogen Effects on TGF-β Formation: Role of Thrombospondin-1, αvβ3, and Integrin-Associated ProteinBiochemical and Biophysical Research Communications, 2001
- Modulation of endometrial transforming growth factor β (TGFβ) by tamoxifenEuropean Journal Of Cancer, 2000
- Sclerosing Encapsulating Peritonitis: Early and Late Results of Surgical Management in 32 CasesDigestive Surgery, 1998
- Advances in Peritoneal Dialysis: Towards Improved Efficacy and SafetyBlood Purification, 1998
- Tamoxifen for retroperitoneal fibrosisPublished by Oxford University Press (OUP) ,1997
- Sclerosing encapsulating peritonitis associated with continuous ambulatory peritoneal dialysis: Surgical managementAmerican Journal of Kidney Diseases, 1997
- Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: A report of the Japanese Sclerosing Encapsulating Peritonitis Study GroupAmerican Journal of Kidney Diseases, 1996
- CorrespondenceAmerican Journal of Kidney Diseases, 1996
- Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysisAmerican Journal of Kidney Diseases, 1995